Transdermal therapeutic formulation containing a limonene
May 8, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3023144 3797494 Topical application of prostaglandin hypotensive agents Disinfectant/cleanser compositions exhibiting reduced eye irritancy potential Pesticides containing D-limonene Pharmaceutical preparation for endermic application Base composition for external preparations, pharmaceutical composition for external use and method of promoting percutaneous drug absorption Base composition for medicament and pharmaceutical composition for external medication Method for percutaneously administering physiologically active agents 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles for reducing intraocular pressure Patent #: 4912125 InventorsAssigneeApplicationNo. 700046 filed on 05/08/1991US Classes:514/763, Carbocyclic514/165, Aspirin per se (i.e., 2-(acetyloxy)benozic acid)514/270, Barbituric acid or derivative (including thioanalogs)514/404, Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent514/420, Indomethacine per se or ester thereof514/570, Carboxy or salt thereof only attached indirectly to the benzene ring514/663, Acyclic514/667, C-O-group containing514/686, Two benzene rings bonded directly to the same C=O514/817, ANESTHETIC, TOPICAL514/947Topical applicationExaminersPrimary: Raymond, Richard L.Assistant: Hollinden, Gary E. Attorney, Agent or FirmInternational ClassesA61K 031/015A61K 031/60 A61K 031/515 Foreign Application Priority Data1989-02-03 JPAbstractA transdermal therapeutic formulation comprising d-limonene and at least one pharmaceutically active substance wherein the content of the d-limonene is in the range from 0.1 to 2 weight percent, based on the total amount of the formulation. The transdermal therapeutic formulation has an excellent percutaneous absorption, is safe and is capable of delivering desired pharmaceutically active substances to a desired location of treatment or to the entire body of a patient through the circulatory system and is thus effective for curing various diseases.Other References
Field of SearchCarbocyclicMISCELLANEOUS (E.G., HYDROCARBONS, ETC.) Topical application Aspirin per se (i.e., 2-(acetyloxy)benozic acid) Barbituric acid or derivative (including thioanalogs) Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent Indomethacine per se or ester thereof Carboxy or salt thereof only attached indirectly to the benzene ring Acyclic C-O-group containing Two benzene rings bonded directly to the same C=O ANESTHETIC, TOPICAL | |
